MedTrace Logo

Benzodiazepines Deprescribing in Nursing Homes: Intervention Feasibility

NCT05929443 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-07-03

No results posted yet for this study

Summary

The goal of this feasibility study is to evaluate the feasibility of a complex intervention towards benzodiazepines and Z-drugs deprescribing in older adults living in the Belgian nursing home setting.

The main questions it aims to answer are:

* Is the intervention we developped feasible
* To what extent will the intervention be implemented in nursing homes
* To what extent is the design of the recruitment and data collection process feasible and acceptable for all participants

Participants will benefit from a complex intervention implemented at the level of the nursing home, encompassing process and goals setting, healthcare providers education, environmental adaptations, audit and feedback on benzodiazepines use, use of educational leaflet with residents and relatives, and multidisciplinary work.

Researchers will compare this intervention to usual care, to see if the intervention is feasible, and to gather first data on intervention effectiveness in benzodiazepines deprescriping.

Conditions

  • Benzodiazepines Deprescribing

Interventions

OTHER

END-IT intervention for nursing homes

Complex intervention, as described in the arm/group descriptions

Sponsors & Collaborators

  • EBPracticenet

    collaborator UNKNOWN

  • Fonds National de la Recherche scientifique (FNRS)

    collaborator UNKNOWN

  • Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Anne Spinewine, PhD · UCLouvain / Louvain Drug Research Institute / Clinical pharmacy research group

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-22
Primary Completion
2024-01-31
Completion
2024-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05929443 on ClinicalTrials.gov